OVCA1: emerging as a bona fide tumor suppressor: Figure 1.
Open Access
- 1 February 2004
- journal article
- editorial
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 18 (3) , 245-248
- https://doi.org/10.1101/gad.1184004
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian CancerCell, 2003
- Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiationOncogene, 2003
- TP53 and ovarian cancerHuman Mutation, 2003
- Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumorsNature Genetics, 2003
- OVCA2 is downregulated and degraded during retinoid-induced apoptosisInternational Journal of Cancer, 2002
- Cloning, Structure, and Expression of the Mouse Ovca1 GeneBiochemical and Biophysical Research Communications, 2001
- Analysis of Allelic Imbalance on Chromosome 17p13 in Stage I and Stage II Epithelial Ovarian CancersGynecologic Oncology, 1998
- Cloning and Localization of a Human Diphthamide Biosynthesis-like Protein-2 Gene,DPH2L2Genomics, 1998
- A cDNA from the ovarian cancer critical region of deletion on chromosome 17p13.3Cancer Letters, 1996
- Allelic loss on chromosome 17 in human ovarian cancerInternational Journal of Cancer, 1993